| Q94601440 | "In-Bore" MRI-Guided Prostate Biopsy for Prostate Cancer Diagnosis: Results from 140 Consecutive Patients |
| Q48351157 | A 12-year follow-up of ANNA/C-TRUS image-targeted biopsies in patients suspicious for prostate cancer. |
| Q40167634 | A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy |
| Q37507776 | A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies |
| Q55517990 | A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA. |
| Q43083508 | A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients |
| Q40565617 | Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy |
| Q47113442 | Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis |
| Q93360733 | Advances in prostate cancer imaging |
| Q87073541 | Advantages of single-puncture transperineal saturation biopsy of prostate: analysis of outcomes in 125 patients using our scheme |
| Q42363869 | Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study |
| Q36937699 | Are more low-risk prostate cancers detected by repeated biopsy? A retrospective pilot study |
| Q41907809 | Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database |
| Q39679092 | Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients |
| Q34506849 | Clinicopathologic differences between prostate cancers detected during initial and repeat transrectal ultrasound-guided biopsy in Korea |
| Q92322970 | Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml |
| Q38822172 | Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications. |
| Q37084223 | Detection rate of clinically insignificant prostate cancer increases with repeat prostate biopsies |
| Q57176079 | Development of a multi-channel NIRS-USG hybrid imaging system for detecting prostate cancer and improving the accuracy of imaging-based diagnosis: a phantom study |
| Q90245229 | Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm |
| Q40061056 | Differences in Postoperative Pathological Outcomes between Prostate Cancers Diagnosed at Initial and Repeat Biopsy |
| Q33714055 | Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect |
| Q40400000 | Discordance between location of positive cores in biopsy and location of positive surgical margin following radical prostatectomy |
| Q39382744 | Does length of prostate biopsy cores have an impact on diagnosis of prostate cancer? |
| Q42991626 | Evaluation of MRI/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches. |
| Q36336025 | Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies |
| Q35178690 | Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness |
| Q63966583 | Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI–TRUS fusion techniques |
| Q37396739 | Fully Automated Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Fusion via a Probabilistic Registration Metric. |
| Q36171334 | INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer |
| Q47564724 | Identifying the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml-1 Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data. |
| Q33891781 | Imaging and intervention in prostate cancer: Current perspectives and future trends |
| Q34893798 | Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session |
| Q45794666 | Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P. |
| Q55282801 | Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review. |
| Q37427381 | Is it time to consider a role for MRI before prostate biopsy? |
| Q42119774 | Limitations of a contemporary prostate biopsy: The blind march forward |
| Q51121574 | MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland. |
| Q80534791 | MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results |
| Q27002672 | MRI of localized prostate cancer: coming of age in the PSA era |
| Q38462421 | MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer. |
| Q41829707 | MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors |
| Q35068260 | MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men. |
| Q58915161 | Magnetic resonance image-guided biopsies with a high detection rate of prostate cancer |
| Q37719273 | Modalities for imaging of prostate cancer |
| Q39410146 | Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer |
| Q38294506 | Multiparametric MRI-targeted TRUS prostate biopsies using visual registration |
| Q35555399 | Novel prostate cancer biomarkers derived from autoantibody signatures |
| Q38109083 | PET/MR in prostate cancer: technical aspects and potential diagnostic value |
| Q40928990 | PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer. |
| Q35700730 | PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer |
| Q38937411 | Pathologic findings in patients with targeted magnetic resonance imaging-guided prostate needle core biopsies |
| Q39477975 | Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting |
| Q64264017 | Photoacoustic tomography for imaging the prostate: a transurethral illumination probe design and application |
| Q35019408 | Prostate biopsy for the interventional radiologist |
| Q24648547 | Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy |
| Q41992191 | Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate |
| Q36795496 | Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint |
| Q39564842 | Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy |
| Q42418519 | Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease |
| Q38218443 | Random biopsy: when, how many and where to take the cores? |
| Q38223431 | Real-time elastography of the prostate |
| Q33805477 | Reduced Rate of Repeated Prostate Biopsies Observed in ConfirmMDx Clinical Utility Field Study |
| Q39802969 | Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link? |
| Q37963657 | Risk-based prostate cancer screening. |
| Q36872828 | Robotic mechanical localization of prostate cancer correlates with magnetic resonance imaging scans |
| Q26768765 | Role of multiparametric magnetic resonance imaging in early detection of prostate cancer |
| Q26777066 | Sniffing out prostate cancer: a new clinical opportunity |
| Q47289972 | Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning |
| Q41214926 | Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results |
| Q36579232 | Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device |
| Q89968895 | Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam |
| Q27027567 | Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer |
| Q33848437 | The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer? |
| Q79886462 | The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique |
| Q38825859 | The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population |
| Q36523352 | The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes |
| Q38211603 | The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used? |
| Q36110346 | Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer |
| Q38141791 | Transperineal biopsy of the prostate--is this the future? |
| Q45986944 | Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. |
| Q49573604 | Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted |
| Q48453091 | Using biopsy to detect prostate cancer. |
| Q42558314 | Using the epigenetic field defect to detect prostate cancer in biopsy negative patients |
| Q37964563 | Value of multiparametric MRI in the work-up of prostate cancer |
| Q37381526 | Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen |
| Q81786067 | [Impact of elastography in clinical diagnosis of prostate cancer. A comparison of cancer detection between B-mode sonography and elastography-guided 10-core biopsies] |
| Q52983024 | [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy]. |